Replies to post #6294 on Regen BioPharma Inc (RGBP)

[GM_FSJ]

While chemotherapy and radiation therapy non-selectively kill all replicating cells, both cancer and healthy cells, thus causing severe toxicity, targeted therapies such as kinase inhibitors (e.g.: Gleevec by Novartis $4.7 billion in 2012)1 and proteasome inhibitors (e.g.: Velcade by J&J and Takeda $2.3 billion in sales in 2012)2 specifically inhibit molecular processes of cancer cells but not other multiplying cells in the body.